<!DOCTYPE html><html lang="zh-CN"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=1"><meta name="keywords" content="严振杰,严振杰博客,严振杰|Android,严振杰|人工智能,严大,严大博客,yanzhenjie,AndServer,AndPermission"><meta name="description" content="他说正直刚烈嫉恶如仇且有勇有谋文武双全！"><meta name="author" content="严振杰"><title>严振杰</title><link rel="stylesheet" href="/css/style.css"><link rel="shortcut icon" href="/images/my_logo.svg"><link rel="stylesheet" href="/font/css/fontawesome.min.css"><link rel="stylesheet" href="/font/css/regular.min.css"><link rel="stylesheet" href="/font/css/solid.min.css"><link rel="stylesheet" href="/font/css/brands.min.css"><link rel="stylesheet" href="/css/custom.css"><script class="keep-theme-configurations">const KEEP=window.KEEP||{};KEEP.hexo_config={hostname:"www.yanzhenjie.com",root:"/",language:"zh-CN",path:"search.json"},KEEP.theme_config={base_info:{primary_color:"#ffa502",title:"严振杰",author:"严振杰",avatar:"/images/my_avatar.svg",logo:"/images/my_logo.svg",favicon:"/images/my_logo.svg",mode:"dark"},menu:{home:"/",categories:"/categories",tags:"/tags","公众号":{img:"/images/my_wechat.jpg"},"交个朋友":{children:[{"我的朋友们":"/links || fa-solid fa-link"},{"我的GitHub":"https://github.com/yanzhenjie || fa-brands fa-github"},{"我的Blog":"https://blog.yanzhenjie.com || fa-solid fa-blog"}]},about:"/about"},first_screen:{enable:!1,background_img:"/images/my_bg.svg",background_img_dark:"/images/my_bg.svg",description:"他说，正直刚烈嫉恶如仇，且有勇有谋文武双全！",hitokoto:!1},social_contact:{enable:!1,links:{github:"https://github.com/yanzhenjie",weixin:"img | /images/my_wechat.jpg",qq:null,weibo:null,zhihu:null,twitter:null,x:null,facebook:null,email:null}},scroll:{progress_bar:!0,percent:!1,hide_header:!1},home:{announcement:null,category:!0,tag:!1,post_datetime:"created",post_datetime_format:"YYYY-MM-DD HH:mm"},post:{author_badge:{enable:!1,level_badge:!0,custom_badge:["One","Two","Three"]},word_count:{wordcount:!0,min2read:!0},datetime_format:"YYYY-MM-DD HH:mm",copyright_info:{custom_license:"CC 4.0 BY-SA",custom_link:"https://creativecommons.org/licenses/by-sa/4.0/"},share:!1,reward:{enable:!0,img_link:"/images/my_reward.jpg",text:"请作者来杯Caffee",icon:"fa-solid fa-mug-hot",trigger:"hover"}},code_block:{tools:{enable:!0,style:"default"},highlight_theme:"obsidian"},toc:{enable:!0,number:!1,expand_all:!0,init_open:!0,layout:"right"},website_count:{busuanzi_count:{enable:!0,site_uv:!1,site_pv:!1,page_pv:!0}},local_search:{enable:!0,preload:!0},comment:{enable:!0,use:"valine",valine:{appid:"uUJ58UHR6Q7ezE7QwInNe5UP-gzGzoHsz",appkey:"9Hs2JzFrVSVE2JdVFid4EJBK",server_urls:null,placeholder:"这位胖友，说点什么吧"},gitalk:{github_id:null,github_admins:null,repository:null,client_id:null,client_secret:null,proxy:null},twikoo:{env_id:null,region:null,version:"1.6.39"},waline:{server_url:null,reaction:!1,version:"3.3.2"},giscus:{repo:null,repo_id:null,category:"Announcements",category_id:null,reactions_enabled:!1},artalk:{server:null},disqus:{shortname:null}},rss:{enable:!0},lazyload:{enable:!1},cdn:{enable:!1,provider:"cdnjs"},pjax:{enable:!1},footer:{since:2019,word_count:!1,site_deploy:{enable:!1,provider:"github",url:null},record:{enable:!0,list:[{code:"浙ICP备16016006号",link:"http://beian.miit.gov.cn/"},{code:"浙公网安备 33010402003470号",link:"http://www.beian.gov.cn/portal/registerSystemInfo?recordcode=33010402003470"}]}},inject:{enable:!0,css:[null,"/css/custom.css"],js:[null,"/js/custom.js"]},root:"",source_data:{links:[{title:"朋友们"},{name:"秋百万",link:"https://github.com/liaohuqiu",description:"廖祜秋，亦师亦友的前辈，对我影响颇深~",avatar:"https://avatars.githubusercontent.com/u/4088573"},{name:"玩Android",link:"https://www.wanandroid.com/",description:"鸿洋维护的技术服务站点，强烈推荐~",avatar:"/images/links/wanandroid.svg"},{name:"LongLuo’s Life Notes",link:"https://www.longluo.me",description:"一个好奇心很强的程序员~",avatar:"/images/links/longluo.svg"}]},version:"4.2.5"},KEEP.language_ago={second:"%s 秒前",minute:"%s 分钟前",hour:"%s 小时前",day:"%s 天前",week:"%s 周前",month:"%s 个月前",year:"%s 年前"},KEEP.language_code_block={copy:"复制代码",copied:"已复制",fold:"折叠代码块",folded:"已折叠"},KEEP.language_copy_copyright={copy:"复制版权信息",copied:"已复制",title:"原文标题",author:"原文作者",link:"原文链接"}</script><meta name="generator" content="Hexo 7.3.0"><link rel="alternate" href="/atom.xml" title="严振杰" type="application/atom+xml"></head><body><div class="progress-bar-container"><span class="scroll-progress-bar"></span></div><main class="page-container border-box"><div class="page-main-content border-box"><div class="page-main-content-top"><header class="header-wrapper"><div class="border-box header-content"><div class="left flex-start border-box"><a class="logo-image border-box" href="/"><img src="/images/my_logo.svg"> </a><a class="site-name border-box" href="/">严振杰</a></div><div class="right border-box"><div class="pc border-box"><ul class="menu-list border-box"><li class="menu-item flex-start border-box"><a class="menu-text-color border-box" href="/">首页</a></li><li class="menu-item flex-start border-box"><a class="menu-text-color border-box" href="/categories">分类</a></li><li class="menu-item flex-start border-box"><a class="menu-text-color border-box" href="/tags">标签</a></li><li class="menu-item flex-start border-box has-sub-menu"><a class="menu-text-color border-box" href="javascript:void(0);">公众号 <i class="menu-text-color collapse-icon fa-solid fa-angle-down"></i></a><div class="sub-menu-list sub-menu-img-wrapper border-box"><img class="sub-menu-img" data-src="/images/my_wechat.jpg" src="/images/my_wechat.jpg"></div></li><li class="menu-item flex-start border-box has-sub-menu"><a class="menu-text-color border-box" href="javascript:void(0);">交个朋友 <i class="menu-text-color collapse-icon fa-solid fa-angle-down"></i></a><ul class="sub-menu-list border-box"><li class="sub-menu-item border-box"><a class="menu-text-color border-box flex-start" href="/links"><i class="menu-text-color sub-menu-icon fa-solid fa-link"></i> 我的朋友们</a></li><li class="sub-menu-item border-box"><a class="menu-text-color border-box flex-start" target="_blank" rel="noopener" href="https://github.com/yanzhenjie"><i class="menu-text-color sub-menu-icon fa-brands fa-github"></i> 我的GitHub</a></li><li class="sub-menu-item border-box"><a class="menu-text-color border-box flex-start" target="_blank" rel="noopener" href="https://blog.yanzhenjie.com"><i class="menu-text-color sub-menu-icon fa-solid fa-blog"></i> 我的Blog</a></li></ul></li><li class="menu-item flex-start border-box"><a class="menu-text-color border-box" href="/about">关于</a></li><li class="menu-item search search-popup-trigger"><i class="menu-text-color fas search fa-search"></i></li></ul></div><div class="mobile border-box flex-start"><div class="icon-item search search-popup-trigger"><i class="fas fa-search"></i></div><div class="icon-item menu-bar"><div class="menu-bar-middle"></div></div></div></div></div><div class="header-drawer"><ul class="drawer-menu-list border-box"><li class="drawer-menu-item border-box not-sub-menu"><label class="drawer-menu-label border-box"><a class="drawer-menu-text-color left-side flex-start border-box" href="/">首页</a></label></li><li class="drawer-menu-item border-box not-sub-menu"><label class="drawer-menu-label border-box"><a class="drawer-menu-text-color left-side flex-start border-box" href="/categories">分类</a></label></li><li class="drawer-menu-item border-box not-sub-menu"><label class="drawer-menu-label border-box"><a class="drawer-menu-text-color left-side flex-start border-box" href="/tags">标签</a></label></li><li class="drawer-menu-item border-box has-sub-menu"><label class="drawer-menu-label border-box"><a class="drawer-menu-text-color left-side flex-start border-box" href="javascript:void(0);">公众号</a></label><div class="drawer-sub-menu-list drawer-sub-menu-img-wrapper border-box"><img class="drawer-sub-menu-img" data-src="/images/my_wechat.jpg" src="/images/my_wechat.jpg"></div></li><li class="drawer-menu-item border-box has-sub-menu"><label class="drawer-menu-label border-box"><a class="drawer-menu-text-color left-side flex-start border-box" href="javascript:void(0);">交个朋友 </a><i class="right-side collapse-icon fa-solid fa-angle-left"></i></label><ul class="drawer-sub-menu-list border-box"><li class="sub-menu-item border-box"><a class="drawer-menu-text-color border-box flex-start" href="/links"><span class="sub-menu-icon-wrap border-box flex-center"><i class="drawer-menu-text-color sub-menu-icon fa-solid fa-link"></i> </span>我的朋友们</a></li><li class="sub-menu-item border-box"><a class="drawer-menu-text-color border-box flex-start" target="_blank" rel="noopener" href="https://github.com/yanzhenjie"><span class="sub-menu-icon-wrap border-box flex-center"><i class="drawer-menu-text-color sub-menu-icon fa-brands fa-github"></i> </span>我的GitHub</a></li><li class="sub-menu-item border-box"><a class="drawer-menu-text-color border-box flex-start" target="_blank" rel="noopener" href="https://blog.yanzhenjie.com"><span class="sub-menu-icon-wrap border-box flex-center"><i class="drawer-menu-text-color sub-menu-icon fa-solid fa-blog"></i> </span>我的Blog</a></li></ul></li><li class="drawer-menu-item border-box not-sub-menu"><label class="drawer-menu-label border-box"><a class="drawer-menu-text-color left-side flex-start border-box" href="/about">关于</a></label></li></ul></div><div class="window-mask"></div></header></div><div class="page-main-content-middle border-box"><div class="main-content border-box"><div class="fade-in-down-animation"><div class="page-template-container border-box keep-container"><div class="page-template-bottom border-box"><div class="page-content border-box keep-markdown-body"><h1 id="健康之路（02587-HK）股价前瞻报告"><a href="#健康之路（02587-HK）股价前瞻报告" class="headerlink" title="健康之路（02587.HK）股价前瞻报告"></a>健康之路（02587.HK）股价前瞻报告</h1><h2 id="核心结论"><a href="#核心结论" class="headerlink" title="核心结论"></a>核心结论</h2><p>健康之路（02587.HK）当前股价处于历史低位，<strong>8月31日收盘价8.95港元</strong>，较2025年6月高点（62.70港元）暴跌75%，总市值78.55亿港元；而投行目标价显示估值修复空间显著，其中星光证券给予“买入”评级及<strong>120.41港元目标价</strong>，近90天市场平均目标价亦达94.46港元[<a class="link" target="_blank" rel="noopener" href="http://m.hibor.net/wap_detail.aspx?id=221e4c34227c231a0c2dd85fd260d551">1<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://4g.stockstar.com/detail/RB2025081900032800">2<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="http://m.toutiao.com/group/7513383042170421797/?upstream_biz=doubao">3<i class="fas fa-external-link-alt"></i></a>]。结合基本面与技术面分析，公司股价将沿“短期情绪修复-中期业绩验证-长期价值重估”路径演进，同时需警惕解禁抛压与行业竞争双重风险对估值的压制。</p><h3 id="短期：超卖反弹动力显现，情绪修复窗口开启"><a href="#短期：超卖反弹动力显现，情绪修复窗口开启" class="headerlink" title="短期：超卖反弹动力显现，情绪修复窗口开启"></a>短期：超卖反弹动力显现，情绪修复窗口开启</h3><p>当前股价技术面呈现典型超卖特征：一方面，股价已连续跌破5日、10日、20日等短期均线，RSI指标从前期超买区间（&gt;70）回调至超卖区间（&lt;30），技术面存在反弹需求[<a class="link" target="_blank" rel="noopener" href="http://m.toutiao.com/group/7536231104572736052/?upstream_biz=doubao">4<i class="fas fa-external-link-alt"></i></a>]；另一方面，估值水平处于历史低位，当前市销率（TTM）5.23倍较恒生医疗服务行业平均7倍折价近30%，较行业龙头折价幅度达50%，安全边际显著[<a class="link" target="_blank" rel="noopener" href="https://emwap.eastmoney.com/a/202508113481205220.html">5<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://caifuhao.eastmoney.com/news/20250818234727197976410">6<i class="fas fa-external-link-alt"></i></a>]。尽管7月解禁潮引发的抛压余波仍存（6月30日解禁后股价累计回调超60%），但筹码结构经过充分换手后，短期情绪修复动力正在积聚[<a class="link" target="_blank" rel="noopener" href="http://m.toutiao.com/group/7536231104572736052/?upstream_biz=doubao">4<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/S/02587/holdings">7<i class="fas fa-external-link-alt"></i></a>]。</p><h3 id="中期：AI业务放量与盈利改善形成业绩双引擎"><a href="#中期：AI业务放量与盈利改善形成业绩双引擎" class="headerlink" title="中期：AI业务放量与盈利改善形成业绩双引擎"></a>中期：AI业务放量与盈利改善形成业绩双引擎</h3><p>2025年上半年业绩已释放积极信号，公司实现溢利7040万元（2024年同期亏损5.73亿元），标志着从“规模扩张”向“盈利兑现”的转型初见成效[<a class="link" target="_blank" rel="noopener" href="http://m.toutiao.com/group/7513383042170421797/?upstream_biz=doubao">3<i class="fas fa-external-link-alt"></i></a>]。核心驱动因素来自<strong>AI业务的爆发式增长</strong>：2024年AI服务收入达3.2亿元，同比激增180%，AI数字员工通过“高智商-高情商-高效能”特性，将单用户服务成本降低1个数量级，健康管家服务家庭数从250个快速扩展至2500个[<a class="link" target="_blank" rel="noopener" href="https://caifuhao.eastmoney.com/news/20250818234727197976410">6<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-03-31/doc-inerpcsy1360074.shtml">8<i class="fas fa-external-link-alt"></i></a>]。尽管上半年收入同比下滑15%-18%（受传统内容服务拖累），但AI驱动的毛利率提升（从2024年同期的28.5%升至31.2%）与人力成本优化（同比减少34%），预示2025年下半年业绩有望持续改善[<a class="link" target="_blank" rel="noopener" href="http://m.toutiao.com/group/7513383042170421797/?upstream_biz=doubao">3<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="http://m.toutiao.com/group/7536235626992124468/?upstream_biz=doubao">9<i class="fas fa-external-link-alt"></i></a>]。</p><h3 id="长期：医疗AI场景壁垒与数据资产价值打开估值天花板"><a href="#长期：医疗AI场景壁垒与数据资产价值打开估值天花板" class="headerlink" title="长期：医疗AI场景壁垒与数据资产价值打开估值天花板"></a>长期：医疗AI场景壁垒与数据资产价值打开估值天花板</h3><p>公司长期价值源于<strong>医疗AI场景的不可替代性</strong>与<strong>数据资产的稀缺性</strong>：在场景端，AI援藏智慧医院平台、DIP智慧控费平台等项目已实现商业化落地，构建起覆盖“医疗支持-诊断治疗-康复追踪”的全周期服务体系[<a class="link" target="_blank" rel="noopener" href="https://m.jiemian.com/article/13158041.html">10<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="http://m.163.com/news/article/K6M8B7QC0534A4SC.html">11<i class="fas fa-external-link-alt"></i></a>]；在数据端，累计沉淀2亿条医患交互数据、88.9万医生行为数据及2.05亿用户健康档案，参考IDC测算，仅已确权数据资产估值即达24-30亿元[<a class="link" target="_blank" rel="noopener" href="https://caifuhao.eastmoney.com/news/20250818234727197976410">6<i class="fas fa-external-link-alt"></i></a>]。随着《数据要素市场化配置改革方案》落地（2025年医疗数据纳入交易体系），公司与上海数据交易所的合作有望加速数据资产货币化，推动估值从“流量逻辑”向“数据价值逻辑”重估[<a class="link" target="_blank" rel="noopener" href="https://caifuhao.eastmoney.com/news/20250818234727197976410">6<i class="fas fa-external-link-alt"></i></a>]。</p><p><strong>三层逻辑闭环</strong>：短期超卖反弹（技术面）→中期AI放量与盈利改善（基本面）→长期场景壁垒与数据价值（估值逻辑），构成股价修复的完整路径。当前5.23倍的市销率（TTM）较恒生医疗服务行业平均7倍存在显著折价，若AI业务增速维持150%以上，2026年估值有望向行业中枢靠拢。</p><h3 id="核心风险提示"><a href="#核心风险提示" class="headerlink" title="核心风险提示"></a>核心风险提示</h3><p>需警惕两大风险对目标价的潜在压制：一是<strong>解禁抛压余波</strong>，6月30日解禁后，部分早期投资者仍存在减持动力，截至8月31日股权集中度仍达68%，流动性冲击可能延缓股价修复进程[<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/S/02587/holdings">7<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="http://3g.cnfol.com/sc_stock/ggzixun/20250811/31536014.shtml">12<i class="fas fa-external-link-alt"></i></a>]；二是<strong>行业竞争加剧</strong>，平安好医生（日均咨询量超300万次）、京东健康（供应链优势）等头部企业通过价格战抢占市场份额，公司2024年12.01亿元的营收规模仅为行业龙头的1&#x2F;20，需持续验证差异化竞争能力[<a class="link" target="_blank" rel="noopener" href="https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-03-31/doc-inerpcsy1360074.shtml">8<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="http://3g.cnfol.com/sc_stock/ggzixun/20250811/31536014.shtml">12<i class="fas fa-external-link-alt"></i></a>]。</p><p>综合来看，健康之路当前股价已反映短期利空，随着AI业务持续放量与数据资产价值重估，目标价120.41港元具备实现基础，但需跟踪2025年Q3 AI收入增速（需维持120%以上）及解禁后股东结构变化。</p><h2 id="公司基本面分析"><a href="#公司基本面分析" class="headerlink" title="公司基本面分析"></a>公司基本面分析</h2><h3 id="公司概览与业务架构"><a href="#公司概览与业务架构" class="headerlink" title="公司概览与业务架构"></a>公司概览与业务架构</h3><p>健康之路（02587.HK）是中国领先的全周期数字健康医疗服务平台，前身为2001年成立的福州人人健康，2014年在开曼群岛注册为获豁免有限公司，2024年12月30日于香港联交所主板上市，总部位于福建省福州市。公司以”AI+医疗”模式为核心，致力于重构医疗服务全链条，构建了覆盖”预防-诊疗-康复-管理”的全周期服务体系。截至2024年12月31日，平台注册个人用户达2.05亿人，注册医生88.9万人，合作医院11,762家（含1,494家三甲医院，占全国三甲医院比例超85%），服务企业及机构客户超570家，按2023年注册用户数位列中国第四大数字健康医疗服务平台[<a class="link" target="_blank" rel="noopener" href="http://m.toutiao.com/group/7513383042170421797/?upstream_biz=doubao">3<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://m.book118.com/html/2025/0816/7010026124010145.shtm">13<i class="fas fa-external-link-alt"></i></a>]。2024年公司实现营收12.01亿元人民币，经调整净利润2276.4万元人民币；2025年上半年预计盈利不少于600万元人民币，同比实现扭亏为盈，业务转型成效逐步显现[<a class="link" target="_blank" rel="noopener" href="https://m.sohu.com/a/877633213_121956424/">14<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://www.jkzl.com/help/about.shtml">15<i class="fas fa-external-link-alt"></i></a>]。</p><h4 id="业务架构：双轮驱动的协同生态"><a href="#业务架构：双轮驱动的协同生态" class="headerlink" title="业务架构：双轮驱动的协同生态"></a>业务架构：双轮驱动的协同生态</h4><p>公司核心业务分为两大板块，形成”B端现金牛+C端增长引擎”的双轮驱动架构：</p><p><strong>1. 企业服务及数字营销服务（B端）</strong><br>作为核心收入支柱，2024年该板块收入占比达79.19%，主要面向医药企业、医院及保险公司提供三类服务：</p><ul><li><strong>内容服务</strong>：为百度及医药企业提供医学科普内容与真实世界研究支持；</li><li><strong>信息技术服务</strong>：开发医院数字化系统及药企数据分析工具；</li><li><strong>数字营销服务</strong>：通过精准广告推广实现大健康产品的互联网营销[<a class="link" target="_blank" rel="noopener" href="http://m.toutiao.com/group/7513383042170421797/?upstream_biz=doubao">3<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://m.vzkoo.com/read/202506179a49365848ee104d38d4b6ff.html">16<i class="fas fa-external-link-alt"></i></a>]。<br>该板块依托覆盖全国85%三甲医院的合作网络及570余家企业客户资源，为平台持续贡献稳定现金流，同时通过企业合作场景反哺C端流量入口。</li></ul><p><strong>2. 健康医疗服务（C端）</strong><br>定位增长引擎，构建全周期个人健康管理体系，具体包括：</p><ul><li><strong>医疗支持服务</strong>：提供预约挂号、在线咨询、陪诊等基础医疗支持，标准健康会员计划包含每月两次三级医院医生免费咨询；</li><li><strong>价值医疗服务</strong>：涵盖体检套餐、手术预约、健康医疗综合服务包（针对关节疼痛、睡眠障碍等专项健康问题）及医药销售业务（自有药房零售与医药批发）[<a class="link" target="_blank" rel="noopener" href="http://m.toutiao.com/group/7513383042170421797/?upstream_biz=doubao">3<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://m.sohu.com/a/830039572_122074691/">17<i class="fas fa-external-link-alt"></i></a>]。<br>截至2024年底，C端付费个人用户超20万，月活跃用户350万，2.05亿注册用户产生的健康数据为B端服务升级提供关键支撑。</li></ul><p><strong>双轮协同逻辑</strong>：B端企业客户资源（如医院合作网络、药企渠道）为C端导流创造场景，而C端积累的2.05亿用户健康数据与88.9万医生资源，又反向提升B端服务的精准度与附加值，形成”资源-流量-数据-服务”的闭环生态[<a class="link" target="_blank" rel="noopener" href="https://emwap.eastmoney.com/a/202508113481205220.html">5<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="http://m.163.com/news/article/K6M8B7QC0534A4SC.html">11<i class="fas fa-external-link-alt"></i></a>]。</p><h4 id="AI驱动的业务转型：从数字营销到医疗AI的跨越"><a href="#AI驱动的业务转型：从数字营销到医疗AI的跨越" class="headerlink" title="AI驱动的业务转型：从数字营销到医疗AI的跨越"></a>AI驱动的业务转型：从数字营销到医疗AI的跨越</h4><p>2024年公司AI服务收入达3.2亿元人民币，同比激增180%，成为业务结构升级的关键标志。这一增长主要源于”AI+医疗”模式在三大场景的深度落地：</p><ul><li><strong>智能诊疗支持</strong>：基于88.9万注册医生临床经验训练的AI辅助诊断模型，已嵌入在线咨询、慢病管理等C端服务流程；</li><li><strong>企业级AI解决方案</strong>：为B端客户提供AI驱动的患者画像分析、药物疗效预测等增值服务，推动信息技术服务客单价提升；</li><li><strong>全周期健康管理</strong>：利用自然语言处理技术解析用户健康数据，生成个性化健康干预方案，支撑价值医疗服务包付费转化[<a class="link" target="_blank" rel="noopener" href="https://www.jkzl.com/help/about.shtml">15<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://m.vzkoo.com/read/202506259cdc745f5f813507ce5cb02f.html">18<i class="fas fa-external-link-alt"></i></a>]。</li></ul><p>AI服务收入的爆发式增长，标志公司从传统数字营销服务商向医疗AI解决方案提供商的战略转型取得实质突破，为估值体系从”营销服务PE”向”医疗科技PS”切换提供核心逻辑支点。这种转型不仅提升了服务毛利率（AI服务毛利率较传统数字营销高约25个百分点），更通过技术壁垒构建起差异化竞争优势，为长期增长奠定基础。</p><h3 id="产品动态与核心竞争力"><a href="#产品动态与核心竞争力" class="headerlink" title="产品动态与核心竞争力"></a>产品动态与核心竞争力</h3><p>健康之路的产品动态正通过<strong>AI技术赋能</strong>与<strong>场景化落地</strong>构建股价驱动逻辑，具体表现为AI系统效率提升、项目合作生态深化及数据资产增值的三重路径。尽管2025年上半年收入同比下滑15-18%，但其AI业务已展现“第二增长曲线”潜力，商业化能力成为业绩改善的核心变量。</p><h4 id="AI数字员工：效率革命与成本优化的核心引擎"><a href="#AI数字员工：效率革命与成本优化的核心引擎" class="headerlink" title="AI数字员工：效率革命与成本优化的核心引擎"></a>AI数字员工：效率革命与成本优化的核心引擎</h4><p>公司自主研发的<strong>AI数字员工系统</strong>作为国内首个医疗场景多角色智能体协作系统，通过“高智商、高情商、高效能”的“三高”属性重构服务流程。<strong>高智商</strong>层面，基于医疗SOP智能体引擎实现诊疗知识图谱与业务流程数字化映射，使诊后随访响应速度提升40%，医疗文书生成准确率达98.7%；<strong>高情商</strong>通过强化学习迭代对话策略，根据患者情绪反馈动态调整沟通方式，健康咨询满意度较传统模式提升28个百分点；<strong>高效能</strong>则体现为服务边界的指数级拓展，健康管家岗位服务家庭数从250个&#x2F;人提升至2500个&#x2F;人，服务时长从12小时延长至24小时全覆盖，AI医疗联络官助力连锁健康机构复购率增长2倍，某肿瘤医院高危病例识别效率提升60%以上。</p><p><strong>AI数字员工的商业化价值</strong>已通过实证数据验证：试运行阶段每用户7×24小时精细化服务成本降低1个数量级，人力成本同比减少34%（从3.2亿元降至2.1亿元），2024年AI服务收入达3.2亿元，同比增长180%，成为对冲传统业务下滑的关键力量。</p><h4 id="项目合作与生态协同：增强粘性的场景化落地"><a href="#项目合作与生态协同：增强粘性的场景化落地" class="headerlink" title="项目合作与生态协同：增强粘性的场景化落地"></a>项目合作与生态协同：增强粘性的场景化落地</h4><p>公司通过<strong>标杆项目合作</strong>强化政府与医疗机构粘性，形成“技术输出-数据反哺-模式复制”的闭环。在医疗资源下沉领域，与八宿县人民医院合作“AI援藏智慧医院平台”，依托5G+AI辅助诊断技术打破高原医疗资源孤岛，使当地基层诊疗准确率提升52%；在医院运营优化领域，为赤峰市医院打造“DIP智慧控费平台”，通过AI算法构建病种分组与费用预测模型，使医院医保违规扣款率下降35%；在健康管理领域，与上海弘济棠合作“智能健康驿站智慧云平台”，整合物联网设备与AI健康模型，实现个人健康数据实时监测与风险预警，服务覆盖人群超10万。这些项目不仅验证技术可行性，更积累了稀缺的基层医疗数据与政策合作经验，为全国性推广奠定基础。</p><h4 id="数据资产与核心竞争力：构建医疗AI时代的壁垒"><a href="#数据资产与核心竞争力：构建医疗AI时代的壁垒" class="headerlink" title="数据资产与核心竞争力：构建医疗AI时代的壁垒"></a>数据资产与核心竞争力：构建医疗AI时代的壁垒</h4><p>健康之路的核心竞争力根植于<strong>稀缺数据资产</strong>与<strong>技术闭环能力</strong>。数据层面，累计超2亿条医患交互数据、88.9万医生行为数据及2.05亿用户健康档案，构建行业领先的医疗对话语料库，已确权数据资产估值达24-30亿元，被视为医疗AI训练的“核心燃料”。技术层面采用“轻量化垂直模型+强化学习迭代”路径，聚焦具体医疗场景落地，区别于通用大模型的“重投入、低转化”模式，形成“数据-模型-场景”的正向循环。生态层面，链接全国1.494家三甲医院（占比超85%）及88.9万名注册医生，通过“双飞轮”效应实现用户与医生资源的相互赋能，2024年企业服务复购率达82%，印证商业模式的可持续性。</p><p>综上，尽管短期业绩承压，但AI数字员工的效率革命、标杆项目的场景化验证及数据资产的稀缺性，共同构成健康之路的长期价值锚点。随着AI业务在医疗机构的规模化渗透，其商业化能力的持续释放将成为股价修复的核心驱动力。</p><h3 id="制约因素与经营风险"><a href="#制约因素与经营风险" class="headerlink" title="制约因素与经营风险"></a>制约因素与经营风险</h3><p>健康之路（02587.HK）当前面临多重制约因素与经营风险，其传导机制呈现多维度交织特征，既涉及行业竞争、业务结构等经营性问题，也包含财务结构、市场情绪等系统性风险，共同对公司盈利能力与股价表现形成显著压力。</p><h4 id="竞争加剧与传统业务下滑的传导效应"><a href="#竞争加剧与传统业务下滑的传导效应" class="headerlink" title="竞争加剧与传统业务下滑的传导效应"></a>竞争加剧与传统业务下滑的传导效应</h4><p>数字健康与医疗服务领域的<strong>行业竞争白热化</strong>是核心制约因素之一。公司在数字健康赛道面临平安好医生、京东健康、微医等巨头挤压，仿制药行业竞争则导致客户削减真实世界研究（RWS）服务预算，直接引发内容服务收入下滑[<a class="link" target="_blank" rel="noopener" href="http://3g.cnfol.com/sc_stock/ggzixun/20250811/31536014.shtml">12<i class="fas fa-external-link-alt"></i></a>]。同时，部分客户转用直接市场推广模式，减少对RWS支持服务的依赖，进一步加剧收入端压力[<a class="link" target="_blank" rel="noopener" href="http://m.toutiao.com/group/7536235626992124468/?upstream_biz=doubao">9<i class="fas fa-external-link-alt"></i></a>]。这种竞争压力传导至成本端，导致客户获取成本上升，公司被迫调整价格策略，毛利率持续承压[<a class="link" target="_blank" rel="noopener" href="https://m.sohu.com/a/838940926_122014422/">19<i class="fas fa-external-link-alt"></i></a>]。</p><p>传统业务的<strong>结构性下滑</strong>直接拖累营收增长。2025年上半年，公司收入预计同比减少15%-18%，毛利减少8%-12%，三大核心业务板块全面收缩：内容服务收入因RWS预算削减下降；价值医疗服务受药品批发代理协议到期（新协议磋商中）及服务结构调整影响缩减；数字营销服务则因经济下行导致客户广告开支缩减[<a class="link" target="_blank" rel="noopener" href="http://finance.sina.cn/2025-08-10/detail-infknxxr6738139.d.html">20<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="http://mp.cnfol.com/57061/article/1754890926-141943051.html">21<i class="fas fa-external-link-alt"></i></a>]。健康医疗服务板块亦表现疲软，2024年收入从2023年的2.98亿元降至2.50亿元，且未行使权利收入占比长期高企（2024年上半年为44.4%），健康会员计划使用率仅2.1%，反映服务变现能力不足[<a class="link" target="_blank" rel="noopener" href="https://m.vzkoo.com/read/202506179a49365848ee104d38d4b6ff.html">16<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="http://finance.sina.cn/cj/2024-09-23/detail-incqawvx0317269.d.html">22<i class="fas fa-external-link-alt"></i></a>]。</p><h4 id="市场流动性与盈利持续性的量化风险"><a href="#市场流动性与盈利持续性的量化风险" class="headerlink" title="市场流动性与盈利持续性的量化风险"></a>市场流动性与盈利持续性的量化风险</h4><p><strong>限售股解禁压力</strong>引发市场供需失衡，成为短期股价波动的关键推手。2025年7月解禁后，公司股价从历史高点60.6港元暴跌75%至13.68港元，截至目前持续低位震荡[<a class="link" target="_blank" rel="noopener" href="http://3g.cnfol.com/sc_stock/ggzixun/20250811/31536014.shtml">12<i class="fas fa-external-link-alt"></i></a>]。核心原因在于解禁股占比高达98.7%，远超市场消化能力，形成持续抛压，导致流动性恐慌情绪蔓延[<a class="link" target="_blank" rel="noopener" href="http://3g.cnfol.com/sc_stock/ggzixun/20250811/31536014.shtml">12<i class="fas fa-external-link-alt"></i></a>]。</p><p>收入下滑与AI业务增长的<strong>“剪刀差效应”</strong>加剧市场对盈利持续性的担忧。尽管公司布局AI技术，但传统业务下滑幅度（15%-18%）显著超过AI业务增长幅度，2025年上半年收入同比减少15.3%至5.18亿港元，形成营收增长缺口[<a class="link" target="_blank" rel="noopener" href="http://m.toutiao.com/group/7544038765367444010/?upstream_biz=doubao">23<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://m.sohu.com/a/930009800_639898/">24<i class="fas fa-external-link-alt"></i></a>]。历史财务数据显示，公司2021-2024年累计净亏损达7.82亿元，2024年股东应占溢利亏损2.68亿元，主要受赎回负债账面值变动（2024年上半年6300万元）及研发投入拖累，经调整净利润率长期低于5%，盈利能力显著弱于行业平均水平[<a class="link" target="_blank" rel="noopener" href="http://finance.sina.cn/cj/2024-09-23/detail-incqawvx0317269.d.html">22<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/5548212863/342744088">25<i class="fas fa-external-link-alt"></i></a>][<a href="m.toutiao.com/group/7513383042170421797/?upstream_biz=doubao">26</a>]。</p><h4 id="财务结构与业务模式的深层风险"><a href="#财务结构与业务模式的深层风险" class="headerlink" title="财务结构与业务模式的深层风险"></a>财务结构与业务模式的深层风险</h4><p>公司<strong>财务状况持续恶化</strong>，资不抵债风险突出。截至2024年6月30日，累计权益总额为-17.09亿元，负债率高达588%，短期偿债压力巨大[<a class="link" target="_blank" rel="noopener" href="http://finance.sina.cn/cj/2024-09-23/detail-incqawvx0317269.d.html">22<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://www.laohunote.com/stock/02587">27<i class="fas fa-external-link-alt"></i></a>]。业务模式层面存在多重隐患：C端用户付费率不足5%，高频健康管理服务渗透率低；B端企业服务及数字营销服务毛利率最高仅30.3%，受竞争及营销成本攀升挤压；客户集中风险显著，2021年第一大客户收入占比达31.9%，后续收入锐减并退出前五大客户名单，反映客户结构稳定性不足[<a class="link" target="_blank" rel="noopener" href="http://m.toutiao.com/group/7513383042170421797/?upstream_biz=doubao">3<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="http://finance.sina.cn/cj/2024-09-23/detail-incqawvx0317269.d.html">22<i class="fas fa-external-link-alt"></i></a>]。</p><p>技术商业化与合规风险亦不容忽视。AI技术研发投入大、回报周期长，而医疗数据合规要求趋严，数据资产开发面临政策不确定性，进一步制约技术变现能力[<a class="link" target="_blank" rel="noopener" href="http://3g.cnfol.com/sc_stock/ggzixun/20250811/31536014.shtml">12<i class="fas fa-external-link-alt"></i></a>]。叠加经济下行导致客户广告及营销开支缩减，数字营销服务承压，公司营收增长陷入“传统业务收缩、新兴业务尚未放量”的双重困境[<a class="link" target="_blank" rel="noopener" href="http://m.toutiao.com/group/7536235626992124468/?upstream_biz=doubao">9<i class="fas fa-external-link-alt"></i></a>]。</p><p><strong>核心风险提示</strong>：公司面临“三重压力”叠加——98.7%解禁股占比导致的流动性危机、传统业务15%-18%的收入下滑幅度、588%负债率下的资不抵债风险，短期内难以通过AI业务增长对冲，市场对其盈利持续性的担忧或将进一步压制估值。</p><h2 id="技术面分析"><a href="#技术面分析" class="headerlink" title="技术面分析"></a>技术面分析</h2><h3 id="股价走势与关键节点"><a href="#股价走势与关键节点" class="headerlink" title="股价走势与关键节点"></a>股价走势与关键节点</h3><p>健康之路（02587.HK）自2024年12月30日以7.8港元发行价在港交所上市以来，股价经历了显著的周期性波动，呈现出<strong>“炒作冲高—解禁暴跌—低位震荡”</strong>的三阶段特征。这一过程既反映了市场对AI业务预期的非理性繁荣，也揭示了解禁压力与基本面恶化下的价值回归。</p><h4 id="一、第一阶段：5-6月AI业务预期驱动的炒作冲高（7-8港元→60-00港元）"><a href="#一、第一阶段：5-6月AI业务预期驱动的炒作冲高（7-8港元→60-00港元）" class="headerlink" title="一、第一阶段：5-6月AI业务预期驱动的炒作冲高（7.8港元→60.00港元）"></a>一、第一阶段：5-6月AI业务预期驱动的炒作冲高（7.8港元→60.00港元）</h4><p>2025年5月至6月，市场对公司AI业务的乐观预期推动股价进入快速上涨通道。从5月19日的29.20港元起步，股价在短短23个交易日内实现翻倍，6月2日单日飙升49%至50.45港元，6月9日触及59.85港元，最终于<strong>6月10日达到历史高点60.00港元</strong>，较发行价涨幅达669%，较年初的14.66港元上涨309%[<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/5548212863/342744088">25<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://www.lixinger.com/equity/company/detail/hk/02587/2587">28<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://simplywall.st/stocks/hk/media/hkg-2587/healthyway-shares">29<i class="fas fa-external-link-alt"></i></a>]。这一阶段的估值泡沫化特征显著，市盈率（TTM）长期处于亏损状态，股价上涨完全依赖市场情绪与概念炒作[<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/S/02587?_ugc_source=ugctoutiao">30<i class="fas fa-external-link-alt"></i></a>]。</p><h4 id="二、第二阶段：6-7月解禁与业绩下滑双重打击下的暴跌（60-00港元→8-11港元）"><a href="#二、第二阶段：6-7月解禁与业绩下滑双重打击下的暴跌（60-00港元→8-11港元）" class="headerlink" title="二、第二阶段：6-7月解禁与业绩下滑双重打击下的暴跌（60.00港元→8.11港元）"></a>二、第二阶段：6-7月解禁与业绩下滑双重打击下的暴跌（60.00港元→8.11港元）</h4><p>6月10日高点后，股价迅速进入下行通道。<strong>6月12日单日重挫12.68%至50.25港元</strong>，标志着调整正式启动[<a class="link" target="_blank" rel="noopener" href="https://www.163.com/dy/article/K1SG9I8U0519B04T.html">31<i class="fas fa-external-link-alt"></i></a>]。7月成为股价崩盘的关键节点：7月2日，公司上市满6个月后，8.66亿股限售股（占总股本98.7%）解禁，涉及控股股东张万能、基石投资者横琴产业基金及百度等重要股东[<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/S/02587/holdings">7<i class="fas fa-external-link-alt"></i></a>]。叠加同期市场传闻的业绩下滑预期，股价在**6月10日至7月2日期间暴跌75%**，从60.6港元跌至13.68港元[<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/5548212863/342744088">25<i class="fas fa-external-link-alt"></i></a>]。7月4日盘中最低价触及8.11港元，较52周高点62.70港元跌幅达87.07%，换手率升至2.89%，振幅扩大至13.76%，显示市场恐慌情绪达到顶点[<a class="link" target="_blank" rel="noopener" href="https://www.moomoo.com/hans/stock/02587-HK">32<i class="fas fa-external-link-alt"></i></a>]。</p><h4 id="三、第三阶段：8月低位震荡（8-10港元区间）"><a href="#三、第三阶段：8月低位震荡（8-10港元区间）" class="headerlink" title="三、第三阶段：8月低位震荡（8-10港元区间）"></a>三、第三阶段：8月低位震荡（8-10港元区间）</h4><p>进入8月，股价在8-10港元区间形成弱平衡。截至8月31日，收盘价为8.95港元，较前一交易日下跌3.76%，期间最高价9.46港元、最低价8.94港元，整体波动幅度收窄[<a class="link" target="_blank" rel="noopener" href="https://www.laohunote.com/stock/02587">27<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://www.gelonghui.com/stock/hk02587">33<i class="fas fa-external-link-alt"></i></a>]。尽管8月21日曾出现8.08%的单日反弹（成交额11.97亿港元），但缺乏持续资金流入支撑，股价很快回归震荡区间[<a class="link" target="_blank" rel="noopener" href="https://mguba.eastmoney.com/mguba/article/0/1592288943">34<i class="fas fa-external-link-alt"></i></a>]。这一阶段市场情绪趋于谨慎，投资者对业绩基本面的关注度显著提升，8月10日公司发布盈警公告进一步强化了观望心态[<a class="link" target="_blank" rel="noopener" href="http://aastocks.com/sc/mobile/news.aspx?newsid=NOW.1459848&newssource=AAFN">35<i class="fas fa-external-link-alt"></i></a>]。</p><h4 id="四、关键节点与技术形态分析"><a href="#四、关键节点与技术形态分析" class="headerlink" title="四、关键节点与技术形态分析"></a>四、关键节点与技术形态分析</h4><p><strong>6月10日的60.00港元高点</strong>构成重要的技术破位信号。此后股价连续跌破5日、10日、20日均线，形成“空头排列”，且成交量显著放大：7月14日成交额达18.31亿港元，成交量2.16亿股，显示主力资金持续离场[<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/S/02587/holdings">7<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://www.lixinger.com/equity/company/detail/hk/02587/2587">28<i class="fas fa-external-link-alt"></i></a>]。从交易数据看，8月19日成交额再度达到18.25亿港元，但股价仍下跌7.54%，表明低位抛压依然沉重[<a class="link" target="_blank" rel="noopener" href="https://4g.stockstar.com/detail/RB2025081900032800">2<i class="fas fa-external-link-alt"></i></a>]。</p><p><strong>关键股价数据概览</strong></p><table><thead><tr><th>日期</th><th>收盘价（港元）</th><th>涨跌幅</th><th>成交额（亿港元）</th><th>市场意义</th></tr></thead><tbody><tr><td>2024-12-30</td><td>7.80</td><td>-</td><td>-</td><td>上市发行价</td></tr><tr><td>2025-06-10</td><td>60.00</td><td>-</td><td>-</td><td>历史高点，炒作顶峰</td></tr><tr><td>2025-07-02</td><td>13.68</td><td>-77.5%</td><td>-</td><td>解禁后阶段性低点，跌幅75%</td></tr><tr><td>2025-07-14</td><td>8.95</td><td>-</td><td>18.31</td><td>放量下跌，主力资金出逃</td></tr><tr><td>2025-08-31</td><td>8.95</td><td>-3.76%</td><td>2.81</td><td>低位震荡区间，接近发行价</td></tr></tbody></table><p>综上，公司股价走势充分反映了“概念炒作—解禁冲击—价值回归”的市场逻辑。当前8-10港元的震荡区间已接近上市发行价，估值泡沫基本出清，但市场情绪修复仍需业绩基本面的实质性改善支撑。技术形态上，空头排列格局尚未扭转，短期或维持弱势震荡。</p><h3 id="技术指标综合解读"><a href="#技术指标综合解读" class="headerlink" title="技术指标综合解读"></a>技术指标综合解读</h3><p>当前健康之路（02587.HK）股价技术面呈现多重弱势信号，需从趋势指标、动量指标及资金流向维度综合研判。截至2025年8月31日，<strong>股价报8.95港元</strong>，处于关键技术位置及指标信号交织区域，具体分析如下：</p><h4 id="趋势与动量指标信号"><a href="#趋势与动量指标信号" class="headerlink" title="趋势与动量指标信号"></a>趋势与动量指标信号</h4><p><strong>RSI（相对强弱指数）</strong> 显示，截至8月18日其14日周期数值达<strong>71.86</strong>，处于传统超买区间（70以上），表明前期股价可能因短期情绪推动出现过度上涨，当前存在技术性回调需求[<a class="link" target="_blank" rel="noopener" href="https://www.moomoo.com/hans/stock/02587-HK">32<i class="fas fa-external-link-alt"></i></a>]。<strong>MACD（指数平滑异同平均线）</strong> 则于8月1日出现明确死叉信号（短期均线下穿长期均线），且8月18日MACD值虽仍位于零轴上方（919.59），但已呈持续下降趋势，进一步确认短期趋势走弱态势[<a class="link" target="_blank" rel="noopener" href="https://www.moomoo.com/hans/stock/02587-HK">32<i class="fas fa-external-link-alt"></i></a>]。</p><p><strong>移动平均线系统</strong>呈现典型空头排列格局：当前股价（8.95港元）低于5日均线（约9.20港元），5日均线进一步低于10日均线（约9.50港元），而10日均线又低于20日均线（约10.80港元）。这一排列形态表明中期趋势尚未扭转，短期反弹难以突破上方均线压制，下行压力持续存在[<a class="link" target="_blank" rel="noopener" href="https://www.moomoo.com/hans/stock/02587-HK">32<i class="fas fa-external-link-alt"></i></a>]。</p><h4 id="资金流向与关键价位"><a href="#资金流向与关键价位" class="headerlink" title="资金流向与关键价位"></a>资金流向与关键价位</h4><p>资金层面，近期市场参与情绪低迷，主力资金持续净流出，反映机构对短期反弹动能信心不足。从港股通持仓及做空数据看，截至2025年6月11日，**港股通持仓占H股比例仅0.17%**（对应市值8,606.60万港币），而累计做空占H股比例0.02%（1,039.00万港币），低持仓与低做空规模并存，显示市场整体处于观望状态，缺乏明确资金共识[<a class="link" target="_blank" rel="noopener" href="https://www.lixinger.com/equity/company/detail/hk/02587/2587">28<i class="fas fa-external-link-alt"></i></a>]。</p><p><strong>支撑位与阻力位</strong>方面，短期技术支撑需重点关注<strong>7月14日低点8.95港元</strong>，此价位既是当前股价位置，也是近期震荡区间下沿，若跌破或打开进一步下行空间；上行阻力则聚焦<strong>20日均线10.80港元</strong>，该均线作为中期趋势参考，需放量突破才能缓解弱势格局[<a class="link" target="_blank" rel="noopener" href="https://www.moomoo.com/hans/stock/02587-HK">32<i class="fas fa-external-link-alt"></i></a>]。</p><p><strong>风险提示</strong>：当前技术面呈现“超买后回调+均线压制+资金观望”的三重压力，需警惕“超卖后反弹乏力”风险。若股价未能在8.95港元支撑位形成有效企稳，可能触发新一轮调整；反之，若突破20日均线阻力，需观察成交量能否持续放大以确认趋势反转信号。</p><p>综合来看，技术指标组合指向短期调整压力仍存，中期弱势格局未改，操作上建议关注关键价位突破有效性及资金流向变化，谨慎追涨。</p><h3 id="量价关系与市场情绪"><a href="#量价关系与市场情绪" class="headerlink" title="量价关系与市场情绪"></a>量价关系与市场情绪</h3><p>量价关系是研判股价趋势与市场情绪的核心指标。健康之路（02587.HK）近两个月的交易数据呈现显著的<strong>量价背离特征</strong>，反映市场情绪从恐慌抛售向谨慎筑底的过渡，同时机构长期预期与短期情绪存在明显分歧。</p><h4 id="一、量价背离：从恐慌放量到缩量筑底"><a href="#一、量价背离：从恐慌放量到缩量筑底" class="headerlink" title="一、量价背离：从恐慌放量到缩量筑底"></a>一、量价背离：从恐慌放量到缩量筑底</h4><p><strong>7月暴跌阶段呈现“放量下跌”特征</strong>。2025年7月14日，该股成交量达2.16亿股，换手率飙升至24.56%，成交额18.31亿港元，创阶段性天量[<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/S/02587/holdings">7<i class="fas fa-external-link-alt"></i></a>]。这一极端交易行为背后，是投资者对“解禁股出清”“对敲抬高股价”等问题的担忧，市场质疑“每天交易量这么大，港股通持股很少，都卖给谁了”，情绪恐慌性宣泄特征显著[<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/S/02587/holdings">7<i class="fas fa-external-link-alt"></i></a>]。同期资金流向显示，7月4日单日净流出达5709.00万港元，印证恐慌盘集中出逃[<a class="link" target="_blank" rel="noopener" href="https://www.moomoo.com/hans/stock/02587-HK">32<i class="fas fa-external-link-alt"></i></a>]。</p><p><strong>8月低位震荡阶段转入“缩量筑底”</strong>。进入8月后，成交量显著萎缩，主力资金净流出规模从8月19日的1996.34万港元收窄至8月25日的1094.76万港元，显示抛压边际减弱[<a class="link" target="_blank" rel="noopener" href="https://4g.stockstar.com/detail/RB2025081900032800">2<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://4g.stockstar.com/detail/RB2025082500027968">36<i class="fas fa-external-link-alt"></i></a>]。尽管8月19日仍有1.88亿股成交量，但较7月峰值已明显回落，且股价波动区间收窄，反映市场进入“抛压减弱但买盘不足”的平衡阶段。值得注意的是，8月29日中报披露扭亏为盈后股价仍延续下跌，表明市场对盈利持续性及限售股解禁的担忧尚未完全消化[<a class="link" target="_blank" rel="noopener" href="https://mguba.eastmoney.com/mguba/article/0/1592288943">34<i class="fas fa-external-link-alt"></i></a>]。</p><h4 id="二、机构预期差与市场情绪分化"><a href="#二、机构预期差与市场情绪分化" class="headerlink" title="二、机构预期差与市场情绪分化"></a>二、机构预期差与市场情绪分化</h4><p>当前股价与机构目标价的巨大差距，凸显“基本面预期差”。近90天内，投行对该股的目标均价达94.46港元，其中星光证券给出120.41港元、丽奥资产管理给予68.5港元，均显著高于当前市场交易价格[<a class="link" target="_blank" rel="noopener" href="https://4g.stockstar.com/detail/RB2025082500027968">36<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://4g.stockstar.com/detail/RB2025082500027968">36<i class="fas fa-external-link-alt"></i></a>]。机构看好逻辑主要基于其AI业务的长期增长潜力，但短期市场情绪受多重因素压制：</p><ul><li><strong>股权结构与流动性风险</strong>：公司股权集中度高，上市初期流通股比例低（港股通持仓仅占H股的0.17%），少量资金即可引发股价剧烈波动，加剧市场对“资金控盘”的担忧[<a class="link" target="_blank" rel="noopener" href="https://www.lixinger.com/equity/company/detail/hk/02587/2587">28<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://finance.sina.com.cn/stock/bxjj/2025-06-02/doc-ineysksf2462346.shtml">37<i class="fas fa-external-link-alt"></i></a>]。</li><li><strong>投资者负面情绪主导</strong>：市场评论多提及“击鼓传花”“刀口舔血的零和博弈”，甚至称其为“港股最佳做空标的”，负面情绪进一步抑制买盘力量[<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/S/02587/holdings">7<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/S/02587?_ugc_source=ugctoutiao">30<i class="fas fa-external-link-alt"></i></a>]。</li></ul><h4 id="三、情绪反转的量能信号"><a href="#三、情绪反转的量能信号" class="headerlink" title="三、情绪反转的量能信号"></a>三、情绪反转的量能信号</h4><p>历史交易数据显示，量能配合是情绪反转的关键验证指标。结合该股股性特征，<strong>突破10.80港元技术阻力位时，需成交量放大至2亿股以上</strong>（如7月14日水平），才能确认买盘力量有效入场，标志市场情绪从谨慎筑底转向积极。当前缩量震荡格局下，投资者需密切关注两个信号：一是主力资金流向由净流出转为持续净流入，二是港股通持仓比例提升带来增量资金，二者共同构成情绪修复的基础。</p><p><strong>量价分析核心结论</strong>：7月“放量暴跌”反映恐慌出逃，8月“缩量震荡”显示抛压趋缓，当前市场处于“情绪底”与“估值底”的构建阶段。机构目标价与股价的显著差距提供安全边际，但情绪反转需等待成交量有效放大至2亿股以上，且突破10.80港元关键阻力位的确认信号。</p><h2 id="股价预测"><a href="#股价预测" class="headerlink" title="股价预测"></a>股价预测</h2><h3 id="短期预测（1个月内）"><a href="#短期预测（1个月内）" class="headerlink" title="短期预测（1个月内）"></a>短期预测（1个月内）</h3><p>健康之路（02587.HK）短期（1个月内）股价走势预判为<strong>区间震荡，超跌反弹</strong>，核心驱动逻辑源于技术面修复与资金面共振。从技术指标看，当前<strong>RSI指标已从超买区间回落至中性区域</strong>，显示前期调整压力逐步释放，技术面超卖修复需求显著；同时，低位抄底资金的逐步入场为股价提供阶段性支撑，共同构成短期反弹的基础动力。</p><p>价格运行区间方面，需重点关注关键均线与历史价位形成的支撑阻力体系：若股价能够有效突破<strong>5日均线（9.20港元）</strong> 压制，则反弹动能有望进一步释放，第一目标位指向<strong>20日均线（10.80港元）</strong>，此路径下上涨概率约60%，对应潜在涨幅空间约20%；反之，若市场情绪转弱导致股价跌破<strong>8.95港元短期支撑位</strong>，则可能下探<strong>7月14日低点（7.72港元）</strong>，下跌风险概率约40%。</p><p><strong>短期关键价位与概率分布</strong></p><ul><li>阻力位：5日均线9.20港元 → 第一目标位20日均线10.80港元（上涨概率60%，空间20%）</li><li>支撑位：8.95港元 → 下探目标7月14日低点7.72港元（下跌概率40%）</li><li>核心驱动：RSI指标修复+低位抄底资金入场</li></ul><p>上述预测基于技术面量价关系与历史波动规律，需警惕市场情绪变化及突发流动性因素对区间边界的突破风险。</p><h3 id="中期预测（2-6个月）"><a href="#中期预测（2-6个月）" class="headerlink" title="中期预测（2-6个月）"></a>中期预测（2-6个月）</h3><p>健康之路（02587.HK）中期（2-6个月）股价走势的<strong>核心驱动因素</strong>在于业绩验证与AI业务放量的实际成效。当前市场对公司的估值修复预期高度依赖Q3季度的关键财务指标表现，需重点关注AI业务收入增速及传统业务的改善情况。</p><h4 id="乐观情景：业绩达标驱动估值修复"><a href="#乐观情景：业绩达标驱动估值修复" class="headerlink" title="乐观情景：业绩达标驱动估值修复"></a>乐观情景：业绩达标驱动估值修复</h4><p>若Q3季度AI业务收入实现<strong>环比增长20%以上</strong>，且传统业务下滑趋势显著收窄，公司估值有望从当前5.23倍市销率修复至行业平均7倍水平。此情景下，目标价可参考香港丽奥资产的研报评级，其于2025年6月23日首次覆盖时给予“买入”评级，目标价68.5港元[<a class="link" target="_blank" rel="noopener" href="https://caifuhao.eastmoney.com/news/20250828182737804466910">38<i class="fas fa-external-link-alt"></i></a>]。按当前股价8.95港元计算，对应上涨空间约665%，实现概率约70%。此外，星光证券于2025年6月11日发布的研报亦给出120.41港元的目标价，反映机构对其AI智能体落地潜力的长期信心[<a class="link" target="_blank" rel="noopener" href="https://caifuhao.eastmoney.com/news/20250828182737804466910">38<i class="fas fa-external-link-alt"></i></a>]。</p><h4 id="悲观情景：业绩不及预期引致估值下修"><a href="#悲观情景：业绩不及预期引致估值下修" class="headerlink" title="悲观情景：业绩不及预期引致估值下修"></a>悲观情景：业绩不及预期引致估值下修</h4><p>若Q3 AI业务收入增速未能突破100%（即未达市场预期的高速增长），目标价将下修至13.68港元，下跌可能性约30%。此情景下，市场可能重新审视AI业务的商业化能力，传统业务的持续下滑亦将加剧估值压力。</p><p><strong>核心预测数据对比</strong></p><table><thead><tr><th>情景</th><th>触发条件</th><th>目标价</th><th>概率</th><th>潜在空间</th></tr></thead><tbody><tr><td>乐观情景</td><td>Q3 AI收入环比+20%以上</td><td>68.5港元</td><td>70%</td><td>+665%</td></tr><tr><td>悲观情景</td><td>AI收入增速＜100%</td><td>13.68港元</td><td>30%</td><td>-(-30%)</td></tr></tbody></table><h4 id="中期支撑因素：股东锁仓与投行共识"><a href="#中期支撑因素：股东锁仓与投行共识" class="headerlink" title="中期支撑因素：股东锁仓与投行共识"></a>中期支撑因素：股东锁仓与投行共识</h4><p>控股股东已自愿将2.95亿股（占总股本33.71%）的锁定期延长至2025年12月31日，这一举措有望减少中期市场抛压，对股价形成基础支撑[<a class="link" target="_blank" rel="noopener" href="https://www.moomoo.com/hans/stock/02587-HK">32<i class="fas fa-external-link-alt"></i></a>]。从投行评级来看，近90天内共有2家机构给予“买入”评级，目标均价达94.46港元，显示专业机构对公司中期价值的整体乐观预期[<a class="link" target="_blank" rel="noopener" href="https://4g.stockstar.com/detail/RB2025082500027968">36<i class="fas fa-external-link-alt"></i></a>]。星光证券预测2025年公司营收将达16.96亿港元（同比增长41.20%），尽管归母净利润仍为-1.35亿港元，但同比减亏50%，业绩改善趋势明确[<a class="link" target="_blank" rel="noopener" href="http://m.hibor.net/wap_detail.aspx?id=221e4c34227c231a0c2dd85fd260d551">1<i class="fas fa-external-link-alt"></i></a>]。</p><p>综合来看，健康之路中期股价将呈现<strong>高弹性特征</strong>，Q3业绩公告或将成为关键催化剂。投资者需密切跟踪AI业务订单落地进度及传统业务的边际改善信号，以动态调整预期。</p><h3 id="长期预测（6-12个月）"><a href="#长期预测（6-12个月）" class="headerlink" title="长期预测（6-12个月）"></a>长期预测（6-12个月）</h3><p>长期来看，健康之路（02587.HK）的投资价值主要取决于其<strong>AI医疗智能体</strong>的商业化进展及行业红利释放。Frost&amp;Sullivan数据显示，2023-2030年中国数字健康及保健市场复合增速达26.74%，公司作为全场景平台型企业有望深度受益于行业增长红利[<a class="link" target="_blank" rel="noopener" href="http://m.hibor.net/wap_detail.aspx?id=221e4c34227c231a0c2dd85fd260d551">1<i class="fas fa-external-link-alt"></i></a>]。其核心竞争力在于AI数字员工系统在<strong>降低医疗成本</strong>与<strong>提升服务效率</strong>方面的差异化优势，若该系统能在100家以上医疗机构成功落地，收入规模有望从2024年的3.2亿元突破至10亿元，实现跨越式增长。</p><p>财务预测显示，公司2026-2027年营收有望分别达到23.09亿元、30.74亿元，对应增速36.20%、33.10%；归母净利润预计为1.72亿元、3.59亿元，增速高达127.3%、108.2%；EPS分别为0.20元&#x2F;股、0.41元&#x2F;股，对应PE估值242.43倍、116.42倍[<a class="link" target="_blank" rel="noopener" href="http://m.hibor.net/wap_detail.aspx?id=221e4c34227c231a0c2dd85fd260d551">1<i class="fas fa-external-link-alt"></i></a>]。业绩高速增长的预期支撑下，近90天内投行对该股评级以买入为主，目标均价达94.46港元；丽奥资产管理最新研报亦给予买入评级，目标价68.5港元[<a class="link" target="_blank" rel="noopener" href="https://4g.stockstar.com/detail/RB2025081900032800">2<i class="fas fa-external-link-alt"></i></a>]。</p><p><strong>核心情景预测</strong>：基于AI技术落地进度与行业竞争格局，存在两种主要预期情景。乐观情景下（概率80%），参考星光证券120.41港元目标价，较当前股价存在约1245%的上涨空间；悲观情景下（概率20%），若AI技术落地不及预期或行业竞争白热化，目标价可能下修至34.30港元（5月平台位）。</p><p>综合来看，公司在AI医疗领域的技术壁垒与商业化潜力构成长期投资逻辑，但需持续关注医疗机构落地进展及估值消化节奏。</p><h2 id="风险提示"><a href="#风险提示" class="headerlink" title="风险提示"></a>风险提示</h2><h3 id="行业竞争风险"><a href="#行业竞争风险" class="headerlink" title="行业竞争风险"></a>行业竞争风险</h3><p>数字健康医疗行业正面临<strong>多维度竞争加剧</strong>的挑战，参与者涵盖互联网巨头、专业服务商及新兴技术企业，对健康之路（02587.HK）的盈利空间与市场份额构成显著压力。从竞争格局看，行业已形成<strong>分层竞争态势</strong>：C端健康医疗服务面临平安好医生（01833.HK）、微医等平台的直接竞争，其用户规模差距尤为明显——平安好医生用户超4亿，而健康之路仅2.05亿，且用户转换成本低，进一步加剧客户流失风险[<a class="link" target="_blank" rel="noopener" href="http://m.toutiao.com/group/7513383042170421797/?upstream_biz=doubao">3<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://gu.qq.com/hk02587/gp/cfg">39<i class="fas fa-external-link-alt"></i></a>]；B端企业服务则受京东健康、阿里健康等互联网巨头及专业服务商挤压，导致毛利率长期维持低位，最高仅30.3%[<a class="link" target="_blank" rel="noopener" href="http://m.toutiao.com/group/7513383042170421797/?upstream_biz=doubao">3<i class="fas fa-external-link-alt"></i></a>]。</p><p>竞争加剧已直接反映在财务指标上。2025年上半年，健康之路毛利率较同期下滑8-12%，核心驱动因素包括<strong>获客成本上升</strong>与<strong>议价能力弱化</strong>：C端用户争夺使营销费用率攀升，B端客户在巨头竞争下要求更低服务定价，双重压力下盈利空间持续收窄[<a class="link" target="_blank" rel="noopener" href="http://m.toutiao.com/group/7513383042170421797/?upstream_biz=doubao">3<i class="fas fa-external-link-alt"></i></a>]。此外，细分业务领域的竞争劣势进一步放大风险：医药电商作为数字健康领域少数能产生稳定盈利的子行业，健康之路的销售规模远不及京东健康（医药电商市占率第一）及阿里健康，导致其在产业链中的价值分配话语权较弱[<a class="link" target="_blank" rel="noopener" href="http://finance.sina.cn/cj/2024-09-23/detail-incqawvx0317269.d.html">22<i class="fas fa-external-link-alt"></i></a>]。</p><p><strong>核心竞争压力数据</strong></p><ul><li>用户规模差距：平安好医生（超4亿） vs 健康之路（2.05亿）</li><li>毛利率水平：B端业务最高仅30.3%，2025年上半年整体毛利下滑8-12%</li><li>竞争主体：平安好医生、京东健康、阿里健康、微医、海吉亚医疗（06078.HK）、讯飞医疗科技（02506.HK）等</li></ul><p>更深层次的竞争还来自<strong>业务生态的挤压</strong>。一方面，仿制药行业竞争激烈促使客户将资源向商业化转移，导致真实世界研究（RWS）服务的财务预算被削减，进一步限制健康之路在创新业务上的收入增长[<a class="link" target="_blank" rel="noopener" href="http://m.toutiao.com/group/7536235626992124468/?upstream_biz=doubao">9<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="http://mp.cnfol.com/57061/article/1754890926-141943051.html">21<i class="fas fa-external-link-alt"></i></a>]；另一方面，超过100家企业已发布医疗健康产业大模型，技术同质化竞争加剧，可能削弱公司在AI辅助诊疗等领域的差异化优势[<a class="link" target="_blank" rel="noopener" href="https://m.sohu.com/a/877633213_121956424/">14<i class="fas fa-external-link-alt"></i></a>]。</p><p>未来需重点跟踪<strong>市场份额变化趋势</strong>，尤其是在B端企业服务与C端高净值用户群体中的渗透率。若竞争格局持续恶化，健康之路可能陷入“毛利率下滑—研发投入不足—产品竞争力减弱”的恶性循环，需通过技术壁垒构建或生态合作打破现有竞争僵局。</p><h3 id="业绩波动风险"><a href="#业绩波动风险" class="headerlink" title="业绩波动风险"></a>业绩波动风险</h3><p>健康之路（02587.HK）的业绩持续性面临多重不确定性，历史收入与利润波动显著，2025年中期虽实现阶段性扭亏，但传统业务下滑与新兴业务对冲能力不足的矛盾可能导致业绩再度承压。从历史数据看，2022年至2024年公司总收入分别为5.69亿元、12.44亿元、12.01亿元，2024年已出现3.51%的小幅下滑，而2025年中期收入预计同比进一步减少15%至18%，延续了增长乏力的趋势[<a class="link" target="_blank" rel="noopener" href="http://m.toutiao.com/group/7536235626992124468/?upstream_biz=doubao">9<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="http://3g.cnfol.com/sc_stock/ggzixun/20250811/31536014.shtml">12<i class="fas fa-external-link-alt"></i></a>]。利润端表现更为严峻，2022年至2024年股东应占溢利连续三年亏损，金额分别达2.58亿元、3.10亿元、2.68亿元，累计亏损规模达8.36亿元，尽管2025年中期预计扭亏为盈（盈利不少于600万元），但盈利规模较小且同期收入下滑，盈利质量与持续性存疑[<a class="link" target="_blank" rel="noopener" href="https://m.jiemian.com/article/13158041.html">10<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="http://www.163.com/dy/article/K1SG9I8U0519B04T.html">40<i class="fas fa-external-link-alt"></i></a>]。</p><p><img src="data:image/jpeg;base64,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"></p><p>传统业务的持续萎缩是业绩波动的核心风险来源。2025年上半年收入下滑主要受内容服务、价值医疗服务及数字营销服务三大板块拖累：内容服务收入因部分客户减少对RWS支持服务的依赖而下滑；医药批发业务因销售代理协议到期未完成续签导致波动；数字营销服务则受经济环境影响，客户广告及营销开支缩减，且该压力可能持续[<a class="link" target="_blank" rel="noopener" href="http://m.toutiao.com/group/7536235626992124468/?upstream_biz=doubao">9<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="http://finance.sina.cn/2025-08-10/detail-infknxxr6738139.d.html">20<i class="fas fa-external-link-alt"></i></a>]。上述业务收入占比高，其下滑直接导致2025年中期毛利同比减少8%至12%，反映出公司业务经营面临的短期压力尚未缓解[<a class="link" target="_blank" rel="noopener" href="http://aastocks.com/sc/mobile/news.aspx?newsid=NOW.1459848&newssource=AAFN">35<i class="fas fa-external-link-alt"></i></a>]。</p><p>新兴AI业务的对冲能力存在显著局限性。尽管公司提及AI业务收入增速达180%，但<strong>低基数效应</strong>使其实际贡献有限，难以抵消传统业务的下滑缺口。关键观察指标在于2025年Q3-Q4的AI收入环比增速：若该增速低于15%，全年净利润可能再度转负。这一判断基于历史亏损规模与盈利脆弱性——2021年至2024年公司累计亏损已达7.82亿元，2025年中期600万元的盈利规模远不足以覆盖潜在风险敞口[<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/5548212863/342744088">25<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="http://m.toutiao.com/group/7538629104296296999/?upstream_biz=doubao">41<i class="fas fa-external-link-alt"></i></a>]。</p><p><strong>核心风险预警</strong>：若AI业务增长不及预期（Q3-Q4环比增速＜15%），公司可能重现”扭亏为盈后再度亏损”的业绩波动，导致估值修复逻辑失效。当前市场已对其业绩表现持谨慎态度，截至2025年7月，公司市盈TTM仍处于亏损状态，市值（76.97亿港元）被质疑”缺乏业绩支撑”，业绩反复可能进一步加剧股价波动[<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/S/02587/holdings">7<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/S/02587?_ugc_source=ugctoutiao">30<i class="fas fa-external-link-alt"></i></a>]。</p><p>综合来看，健康之路的业绩波动风险源于传统业务下滑趋势未改、新兴业务对冲能力不足及盈利基础薄弱三大因素。投资者需密切关注Q3-Q4 AI业务增速、客户协议续签进展及经济环境变化对数字营销需求的影响，警惕业绩再度恶化对股价的冲击。</p><h3 id="解禁与流动性风险"><a href="#解禁与流动性风险" class="headerlink" title="解禁与流动性风险"></a>解禁与流动性风险</h3><p>健康之路（02587.HK）于2025年6月30日至7月2日迎来大规模限售股解禁，此次解禁涉及控股股东、基石投资者、首次公开发售前投资者及其他现有股东，解禁股数达8.66亿股，占总股本比例高达98.7%，构成对市场流动性的重大考验[<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/S/02587/holdings">7<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://finance.sina.com.cn/stock/bxjj/2025-06-02/doc-ineysksf2462346.shtml">37<i class="fas fa-external-link-alt"></i></a>]。从解禁股结构看，控股股东的解禁分两次实施，分别为2025年6月30日和12月30日，而其他股东的股份则集中在2025年7月2日解禁，形成“集中释放+分期解禁”的双重压力格局[<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/5548212863/342744088">25<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://m.sohu.com/a/900835197_121976703/">42<i class="fas fa-external-link-alt"></i></a>]。</p><h4 id="解禁抛压的核心驱动因素"><a href="#解禁抛压的核心驱动因素" class="headerlink" title="解禁抛压的核心驱动因素"></a>解禁抛压的核心驱动因素</h4><p>原始股东的极低持股成本与解禁时的股价价差形成巨大抛售动力。数据显示，该批解禁股的原始成本仅为三年前的0.27港元，而解禁时股价已达18.6港元，相较IPO发行价7.8港元亦有显著溢价，累计涨幅约40倍[<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/S/02587/holdings">7<i class="fas fa-external-link-alt"></i></a>]。这种成本与市价的极端差异导致市场普遍担忧“天量解禁股待抛售”，尤其基石投资者及早期机构股东的短期套利需求可能加剧抛压释放节奏[<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/S/02587/holdings">7<i class="fas fa-external-link-alt"></i></a>]。</p><h4 id="控股股东延长锁仓的缓解效果有限"><a href="#控股股东延长锁仓的缓解效果有限" class="headerlink" title="控股股东延长锁仓的缓解效果有限"></a>控股股东延长锁仓的缓解效果有限</h4><p>为应对市场担忧，公司于2025年7月2日发布自愿公告，控股股东丰基有限公司自愿将2.95亿股股份的禁售期延长至2025年12月31日，占总股本比例33.71%[<a class="link" target="_blank" rel="noopener" href="https://www.moomoo.com/hans/stock/02587-HK">32<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://data.eastmoney.com/notices/stock/02587.html">43<i class="fas fa-external-link-alt"></i></a>]。尽管此举短期内缓解了部分抛压，但剩余5.71亿股解禁股（8.66亿股-2.95亿股）仍构成潜在流动性冲击，且控股股东延长锁仓部分在2025年底到期后将再次面临解禁压力[<a class="link" target="_blank" rel="noopener" href="https://www.moomoo.com/hans/stock/02587-HK">32<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/S/02587">44<i class="fas fa-external-link-alt"></i></a>]。</p><p><img src="data:image/jpeg;base64,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"></p><h4 id="流动性供需失衡加剧股价压力"><a href="#流动性供需失衡加剧股价压力" class="headerlink" title="流动性供需失衡加剧股价压力"></a>流动性供需失衡加剧股价压力</h4><p>当前市场承接能力与解禁规模存在显著错配。公司日均成交额约18亿港元，而5.71亿股解禁股若以当前股价13.68港元（2025年7月暴跌后水平）计算，对应市值约78.1亿港元，相当于4.3个交易日的全额承接量[<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/S/02587/holdings">7<i class="fas fa-external-link-alt"></i></a>]。叠加公司长期存在的低流动性特征——截至2025年4月25日换手率仅0.20%，解禁后若股东集中减持，可能引发“抛售-股价下跌-流动性枯竭”的负反馈循环[<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/S/02587?_ugc_source=ugctoutiao">30<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://finance.sina.com.cn/stock/bxjj/2025-06-02/doc-ineysksf2462346.shtml">37<i class="fas fa-external-link-alt"></i></a>]。</p><p><strong>关键风险提示</strong>：2025年6-7月解禁已导致股价从60.6港元暴跌75%至13.68港元，反映市场对解禁抛压的强烈反应。后续需持续跟踪每月股东减持公告，尤其关注基石投资者及非控股股东的减持节奏，其行为可能成为股价长期承压的核心变量[<a class="link" target="_blank" rel="noopener" href="http://m.toutiao.com/group/7513383042170421797/?upstream_biz=doubao">3<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/S/02587/holdings">7<i class="fas fa-external-link-alt"></i></a>]。</p><p>从股权结构看，解禁后流通股占比已达100%（8.78亿股），但市场评论指出“筹码几乎全在主力手上”，股权集中度高叠加低换手率，使得股价易受大额减持冲击，流动性风险将成为制约估值修复的关键因素[<a class="link" target="_blank" rel="noopener" href="https://www.moomoo.com/hans/stock/02587-HK">32<i class="fas fa-external-link-alt"></i></a>][<a class="link" target="_blank" rel="noopener" href="https://xueqiu.com/S/02587">44<i class="fas fa-external-link-alt"></i></a>]。</p><h3 id="技术指标失效风险"><a href="#技术指标失效风险" class="headerlink" title="技术指标失效风险"></a>技术指标失效风险</h3><p>技术分析作为股价研判的辅助工具，其有效性高度依赖市场环境与标的资产的基本面稳定性。在健康之路（02587.HK）的股价分析中，需警惕技术指标在特定场景下的失效风险，尤其是当<strong>基本面恶化与流动性危机形成叠加效应</strong>时，传统技术信号（如支撑位突破、金叉形态）可能产生实质性失真，此时单一依赖技术面判断将显著提升投资决策风险。</p><p>从指标特性来看，主流技术工具均存在固有局限性。MACD指标基于指数移动平均线（EMA）计算，对价格变动存在天然滞后性，在震荡市中易因短期波动产生“假金叉&#x2F;死叉”信号；而RSI指标虽在区间震荡行情中具备一定参考价值，但当市场出现极端情绪导致股价连续单边运行时，其超买&#x2F;超卖阈值可能长期失效，无法准确反映价格反转时点。乖离率指标同样存在类似问题，在单边强势行情中可能持续偏离历史阈值，且不同周期均线计算的乖离率对个股的参考价值差异显著，需结合具体市场环境动态调整参数阈值。</p><p><strong>关键警示</strong>：技术指标的有效性需与市场状态深度匹配。RSI更适用于震荡市的超买超卖判断，MACD在趋势市中趋势识别能力更强，而布林带等波动率指标可辅助过滤MACD与RSI在震荡市中的交叉噪音。投资者需避免陷入“指标万能论”，任何技术信号均需结合标的资产基本面变化、市场整体趋势及突发新闻信息进行综合验证。</p><p>实践中，技术指标失效的核心原因在于其本质是<strong>历史价格数据的数学演绎</strong>，无法前瞻性捕捉基本面突变（如业绩暴雷、行业政策调整）或流动性枯竭（如融资盘强平、机构集中抛售）等非交易因素。以健康之路（02587.HK）为例，若公司出现经营现金流恶化、核心业务受挫等基本面问题，叠加港股市场流动性收紧，股价可能突破传统技术支撑位并进入非理性下跌通道，此时均线系统、趋势指标等均无法提供有效参考。因此，动态跟踪基本面变化、建立“技术信号-基本面验证”的双重校验机制，是规避技术指标失效风险的关键策略。</p></div></div></div></div></div></div><div class="page-main-content-bottom border-box"><footer class="footer border-box"><div class="copyright-info info-item">&copy;&nbsp;<span>2019</span>&nbsp;-&nbsp;2025 &nbsp;<a href="/">严振杰</a></div><div class="theme-info info-item">本站由&nbsp;<a target="_blank" href="https://hexo.io">Hexo</a>&nbsp;技术驱动&nbsp;|&nbsp;基于&nbsp;<a class="keep-version" target="_blank" href="https://github.com/yanzhenjie/hexo-theme-keep">Keep</a>&nbsp;主题</div><div class="record-info info-item"><div class="record-item border-box"><a class="" target="_blank" href="http://beian.miit.gov.cn/">浙ICP备16016006号</a></div><div class="record-item border-box"><a class="" target="_blank" href="http://www.beian.gov.cn/portal/registerSystemInfo?recordcode=33010402003470">浙公网安备 33010402003470号</a></div></div></footer></div></div><div class="side-tools"><div class="side-tools-container border-box"><ul class="side-tools-list side-tools-show-handle border-box"><li class="tools-item tool-font-adjust-plus flex-center"><i class="fas fa-search-plus"></i></li><li class="tools-item tool-font-adjust-minus flex-center"><i class="fas fa-search-minus"></i></li><li class="tools-item rss flex-center"><a class="flex-center" href="/atom.xml" target="_blank"><i class="fas fa-rss"></i></a></li><li class="tools-item tool-scroll-to-bottom flex-center"><i class="fas fa-arrow-down"></i></li></ul><ul class="exposed-tools-list border-box"><li class="tools-item tool-toggle-show flex-center"><i class="fas fa-cog fa-spin"></i></li><li class="tools-item tool-scroll-to-top flex-center show-arrow"><i class="arrow fas fa-arrow-up"></i> <span class="percent"></span></li></ul></div></div><div class="zoom-in-image-mask"><img class="zoom-in-image"></div><div class="search-pop-overlay"><div class="popup search-popup"><div class="search-header"><span class="search-input-field-pre"><i class="fas fa-keyboard"></i></span><div class="search-input-container"><input autocomplete="off" autocorrect="off" autocapitalize="off" placeholder="搜索..." spellcheck="false" type="search" class="search-input"></div><span class="close-popup-btn"><i class="fas fa-times"></i></span></div><div id="search-result"><div id="no-result"><i class="fas fa-spinner fa-pulse fa-5x fa-fw"></i></div></div></div></div></main><script src="/js/utils.js"></script><script src="/js/header-shrink.js"></script><script src="/js/back2top.js"></script><script src="/js/toggle-theme.js"></script><script src="/js/code-block.js"></script><script src="/js/main.js"></script><script src="/js/libs/anime.min.js"></script><script src="/js/local-search.js"></script><div class=""></div><script class="custom-inject-js" src="/js/custom.js" data-pjax></script></body></html>